Washington University School of Medicine: Sclerosis trials

The registry lists 10 Sclerosis studies with Washington University School of Medicine as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 1Phase 2 1Phase 3 1Phase 4 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Rehabilitation in SOD1 ALS Treated With TofersenEnrolling by invitationNCT05725759
• Ampyra for Optic Neuritis in Multiple SclerosisCompletedNCT01337986Phase 2/3Results posted
• Gut Microbiome and DepressionTerminatedNCT05808101
• Online Self-Compassion Course for pALS (Compassion pALS)CompletedNCT05202743
• Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral SclerosisCompletedNCT03929068Phase 1
• Intermittent Fasting in Multiple SclerosisCompletedNCT03539094Not applicable
• SOD1 Kinetics Measurements in ALS PatientsSuspendedNCT03449212
• Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALSCompletedNCT02686268
• Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MSWithdrawnNCT02675413Phase 4
• Calorie Restriction in Multiple Sclerosis PatientsCompletedNCT02411838Not applicable